Your browser doesn't support javascript.
loading
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.
Huang, Yunda; Zhang, Lily; Karuna, Shelly; Andrew, Philip; Juraska, Michal; Weiner, Joshua A; Angier, Heather; Morgan, Evgenii; Azzam, Yasmin; Swann, Edith; Edupuganti, Srilatha; Mgodi, Nyaradzo M; Ackerman, Margaret E; Donnell, Deborah; Gama, Lucio; Anderson, Peter L; Koup, Richard A; Hural, John; Cohen, Myron S; Corey, Lawrence; McElrath, M Juliana; Gilbert, Peter B; Lemos, Maria P.
Afiliación
  • Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA. yunda@fredhutch.org.
  • Zhang L; Department of Global Health, University of Washington, Seattle, WA, 98196, USA. yunda@fredhutch.org.
  • Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Andrew P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Juraska M; Family Health International, Durham, NC, 27710, USA.
  • Weiner JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Angier H; Thayer School of Engineering, Dartmouth College, Hanover, NH, 03755, USA.
  • Morgan E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Azzam Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Swann E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Edupuganti S; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Rockville, MD, 46340, USA.
  • Mgodi NM; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, 30322, USA.
  • Ackerman ME; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.
  • Donnell D; Thayer School of Engineering, Dartmouth College, Hanover, NH, 03755, USA.
  • Gama L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Anderson PL; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Koup RA; Colorado Antiviral Pharmacology Laboratory and Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-AMC, Aurora, CO, 80045, USA.
  • Hural J; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Cohen MS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Corey L; Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
  • Gilbert PB; Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Lemos MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Nat Commun ; 14(1): 7813, 2023 Nov 28.
Article en En | MEDLINE | ID: mdl-38016958

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Adult / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Adult / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos